From: Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer
sgRNA*
Forward
5′-TAATACGACTCACTATAGATCATGCAGCTCATGCCC-3′
Reverse
5′-TTCTAGCTCTAAAACAAGGGCATGAGCTGCATGAT-3′
cfDNA PCR†
5′-CATGCGAAGCCACACTGAC-3′
5′-CGGACATAGTCCAGGAGGCA-3′